1. P602 Vedolizumab subcutaneous influencing disease course in Constant-care app solution. (27th May 2021) Authors: Nørgaard, J; Malte, R; Charlotte, P L; Mette, B; Eva, F; Petra, W; Dorit, A; Lotte, S; Johan, B; Pia, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗